Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Renata Piccoli

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
FEBS Letters|October 30, 2016
Apolipoprotein A-I: the dual face of a proteinAngela Arciello, Renata Piccoli, Daria Maria Monti
FEBS Letters|April 18, 2002
A new RNase-based immunoconjugate selectively cytotoxic for ErbB2-overexpressing cellsClaudia De Lorenzo, Alessandra Nigro, Renata Piccoli, et al.
Metallomics : Integrated Biometal Science|January 15, 2014
A proteomic approach to investigate the effects of cadmium and lead on human primary renal cellsEugenio Galano, Angela Arciello, Renata Piccoli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2002
A new human antitumor immunoreagent specific for ErbB2Claudia De Lorenzo, Donald B Palmer, Renata Piccoli, et al.
Biochimica Et Biophysica Acta. General Subjects|November 28, 2017
Cell milieu significantly affects the fate of AApoAI amyloidogenic variants: predestination or serendipity?Rosa Gaglione, Giovanni Smaldone, Rocco Di Girolamo, et al.
Biotechnology Letters|September 8, 2010
Expression of human apolipoprotein A-I in Nicotiana tabacumPasquale Chiaiese, Maria Minutolo, Angela Arciello, et al.
Protein Science : a Publication of the Protein Society|January 30, 2009
Structural features for the mechanism of antitumor action of a dimeric human pancreatic ribonuclease variantAntonello Merlino, Giovanna Avella, Sonia Di Gaetano, et al.
Journal of Biotechnology|December 3, 2014
Biocompatibility, uptake and endocytosis pathways of polystyrene nanoparticles in primary human renal epithelial cellsDaria Maria Monti, Daniela Guarnieri, Giuliana Napolitano, et al.
Cancer Research|July 17, 2004
A fully human antitumor immunoRNase selective for ErbB-2-positive carcinomasClaudia De Lorenzo, Angela Arciello, Rosanna Cozzolino, et al.
Biochemistry|March 5, 2010
Aggregation mechanisms of cystatins: a comparative study of monellin and oryzacystatinVeronica Esposito, Fulvio Guglielmi, Stephen R Martin, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
FEBS Letters|October 30, 2016
Apolipoprotein A-I: the dual face of a proteinAngela Arciello, Renata Piccoli, Daria Maria Monti
FEBS Letters|April 18, 2002
A new RNase-based immunoconjugate selectively cytotoxic for ErbB2-overexpressing cellsClaudia De Lorenzo, Alessandra Nigro, Renata Piccoli, et al.
Metallomics : Integrated Biometal Science|January 15, 2014
A proteomic approach to investigate the effects of cadmium and lead on human primary renal cellsEugenio Galano, Angela Arciello, Renata Piccoli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2002
A new human antitumor immunoreagent specific for ErbB2Claudia De Lorenzo, Donald B Palmer, Renata Piccoli, et al.
Biochimica Et Biophysica Acta. General Subjects|November 28, 2017
Cell milieu significantly affects the fate of AApoAI amyloidogenic variants: predestination or serendipity?Rosa Gaglione, Giovanni Smaldone, Rocco Di Girolamo, et al.
Biotechnology Letters|September 8, 2010
Expression of human apolipoprotein A-I in Nicotiana tabacumPasquale Chiaiese, Maria Minutolo, Angela Arciello, et al.
Protein Science : a Publication of the Protein Society|January 30, 2009
Structural features for the mechanism of antitumor action of a dimeric human pancreatic ribonuclease variantAntonello Merlino, Giovanna Avella, Sonia Di Gaetano, et al.
Journal of Biotechnology|December 3, 2014
Biocompatibility, uptake and endocytosis pathways of polystyrene nanoparticles in primary human renal epithelial cellsDaria Maria Monti, Daniela Guarnieri, Giuliana Napolitano, et al.
Cancer Research|July 17, 2004
A fully human antitumor immunoRNase selective for ErbB-2-positive carcinomasClaudia De Lorenzo, Angela Arciello, Rosanna Cozzolino, et al.
Biochemistry|March 5, 2010
Aggregation mechanisms of cystatins: a comparative study of monellin and oryzacystatinVeronica Esposito, Fulvio Guglielmi, Stephen R Martin, et al.
Pageof 3